Inventor · disambiguated record
Helen Sabzevari
Also filed as: SABZEVARI HELEN
5 granted patents·8 pending applications·4 citations·filing 2012–2024
70Inventor score
Top patents by PatentIndex Score
13 records- 0188US11319380B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2019·Granted May 3, 2022·3 cites·11 claims
- 0280US2024368305A1Muc16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2024·Application pending·0 cites
- 0376US11535669B2Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2019·Granted Dec 27, 2022·1 cites·15 claims
- 0475US11981746B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2022·Granted May 14, 2024·0 cites·81 claims
- 0575US11976134B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2022·Granted May 7, 2024·0 cites·70 claims
- 0674US2025325665A1Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2024·Application pending·0 cites
- 0768US12194094B2Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2021·Granted Jan 14, 2025·0 cites·15 claims
- 0866US2024141045A1Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2022·Application pending·0 cites
- 0955US2022220187A1Chimeric receptor therapyPRECIGEN INC·Filed 2022·Application pending·0 cites
- 1041US2019031785A1Multispecific immunomodulatory antigen-binding constructsCOMPASS THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 1138US2018318417A1Multispecific immunomodulatory antigen-binding constructsCOMPASS THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
- 1235US2014308294A1Anti-IL-1R1 Inhibitors For Use in CancerSESHIRE ANITA·Filed 2012·Application pending·0 cites
- 1334US2018251548A1Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf-betaCOMPASS THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →